<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>MRNA Technology on The Coders Blog</title><link>https://thecodersblog.com/tag/mrna-technology/</link><description>Recent content in MRNA Technology on The Coders Blog</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Mon, 11 May 2026 21:25:39 +0000</lastBuildDate><atom:link href="https://thecodersblog.com/tag/mrna-technology/index.xml" rel="self" type="application/rss+xml"/><item><title>A New Hantavirus Vaccine Is in the Works</title><link>https://thecodersblog.com/new-hantavirus-vaccine-development-2026/</link><pubDate>Mon, 11 May 2026 21:25:39 +0000</pubDate><guid>https://thecodersblog.com/new-hantavirus-vaccine-development-2026/</guid><description>&lt;p&gt;The specter of a rapidly spreading, potentially fatal viral illness looms large, not from a novel pathogen, but from an ancient foe re-emerging with devastating consequences. The recent Andes hantavirus outbreak aboard the MV Hondius cruise ship in April/May 2026, resulting in three fatalities and multiple infections, has served as a stark, undeniable wake-up call. It underscores a critical vulnerability: our current defenses against New World hantaviruses are woefully inadequate. Imagine the nightmare scenario where a swift, highly transmissible hantavirus strain emerges, overwhelming our limited capacity to respond, and our most advanced vaccine candidates fail to elicit a sufficient immune response or, worse, cause severe adverse reactions in early human trials. This isn&amp;rsquo;t science fiction; it&amp;rsquo;s the very real risk we face if progress in hantavirus vaccine development stalls, particularly when confronted with the specific challenges posed by New World strains.&lt;/p&gt;</description></item></channel></rss>